QUESTIONS3rd Annual World Congress on Insulin Resistance Syndrome
Venue: TBA
Location: San Francisco, California, United States
| Event Date/Time: Nov 17, 2005 | End Date/Time: Nov 19, 2005 |
| Registration Date: Nov 17, 2005 | |
| Early Registration Date: Aug 25, 2005 | |
| Abstract Submission Date: Sep 30, 2005 | |
| Paper Submission Date: Sep 30, 2005 |
Report as SpamDescription
3rd Annual World Congress ON THE INSULIN RESISTANCE SYNDROME
Clinical manifestations of the Insulin Resistance Syndrome - Metabolic Syndrome X
The congress is organized by the International Committee for Insulin Resistance (ICIR) and is jointly sponsored by “PESI Healthcare” and” Metabolic Endocrine Education Foundation” The program is chaired by Dr. Gerald Reaven , and co-sponsored by American Association of Clinical Endocrinologists (AACE).
This scientific meeting will bring together national and international leaders as well as researches in the clinical practice of the Syndrome.
The world wide epidemic of Insulin Resistance Syndrome and its relation to etiology, ethnicity, and epidemiology of: obesity, dyslipidemia, cardiovascular disease, hypertension, PCOS, gestational diabetes, liver disease (NAFLD), cancer, inflammation and endothelial dysfunction, sleep apnea and mood disorders in childhood, adolescence and adulthood.
This is a CME program and there is a call for abstract
Place:
TBA
San Francisco, CA, USA
Date:
November 17-19, 2005
For information on registration, abstracts submission, accommodations and exhibits please call: (818) 342-1889. Fax (818) 342-1538. insulinresistance@pacbell.net
Clinical manifestations of the Insulin Resistance Syndrome - Metabolic Syndrome X
The congress is organized by the International Committee for Insulin Resistance (ICIR) and is jointly sponsored by “PESI Healthcare” and” Metabolic Endocrine Education Foundation” The program is chaired by Dr. Gerald Reaven , and co-sponsored by American Association of Clinical Endocrinologists (AACE).
This scientific meeting will bring together national and international leaders as well as researches in the clinical practice of the Syndrome.
The world wide epidemic of Insulin Resistance Syndrome and its relation to etiology, ethnicity, and epidemiology of: obesity, dyslipidemia, cardiovascular disease, hypertension, PCOS, gestational diabetes, liver disease (NAFLD), cancer, inflammation and endothelial dysfunction, sleep apnea and mood disorders in childhood, adolescence and adulthood.
This is a CME program and there is a call for abstract
Place:
TBA
San Francisco, CA, USA
Date:
November 17-19, 2005
For information on registration, abstracts submission, accommodations and exhibits please call: (818) 342-1889. Fax (818) 342-1538. insulinresistance@pacbell.net
Venue
Additional Information
PLease visit our website at www.insulinresistance.us
